Question 1

What was Acutaas Chemicals' net profit in Q2 FY27?

Accepted Answer

Consolidated net profit attributable to shareholders was ₹125 crore, up 73.3% from ₹72.2 crore in Q2 FY26 and up 68.6% from ₹74.3 crore in Q1 FY27. Including the minority shareholders' share, total profit was ₹123 crore.

Question 2

How were Acutaas Chemicals' Q2 FY27 results?

Accepted Answer

Both grew from a year earlier: net profit was up 73.3% at ₹125 crore and revenue was up 42.7% at ₹437 crore. The operating margin was 37.4%, up 9.0 percentage points from 28.4% a year earlier. Against Q1 FY27, net profit was up 68.6% and revenue up 32.5%.

Question 3

What was Acutaas Chemicals' operating margin in Q2 FY27?

Accepted Answer

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹163 crore, a margin of 37.4%, against 31.3% in Q1 FY27 and 28.4% in Q2 FY26. EBITDA was ₹176 crore, 40.3% of revenue.

Question 4

What was Acutaas Chemicals' revenue in Q2 FY27?

Accepted Answer

Revenue from operations was ₹437 crore, up 42.7% year on year and up 32.5% from the previous quarter.

Question 5

What was Acutaas Chemicals' EPS in Q2 FY27?

Accepted Answer

Basic earnings per share were ₹15.29, against ₹8.82 in Q2 FY26.

Question 6

What was Acutaas Chemicals' revenue in FY26?

Accepted Answer

Revenue from operations was ₹1,339 crore in FY26 (April 2025–March 2026), up 33.0% from ₹1,007 crore in FY25. It was ₹717 crore in FY24 and ₹617 crore in FY23: up 117.2% over three years, 29.5% a year on average.

Question 7

What was Acutaas Chemicals' net profit in the first half of FY27?

Accepted Answer

Consolidated net profit attributable to shareholders for the first half of FY27 (April–September 2026) was ₹199 crore, up 71.1% from ₹117 crore in the same months a year earlier. Revenue from operations was ₹767 crore, up 49.3%.

Question 8

What is Acutaas Chemicals' net profit margin?

Accepted Answer

Acutaas Chemicals' net profit margin was 28.6% in Q2 FY27 (net profit attributable to shareholders as a share of revenue from operations), against 23.6% in Q2 FY26 (up 5.1 percentage points). For FY26 as a whole it was 26.6%.

Question 9

What was Acutaas Chemicals' net profit in FY26?

Accepted Answer

Consolidated net profit attributable to shareholders was ₹356 crore in FY26 (April 2025–March 2026), up 124.5% from ₹159 crore in FY25. It was ₹42.8 crore in FY24 and ₹83.3 crore in FY23: up 327.7% over three years, 62.3% a year on average.

Question 10

How has Acutaas Chemicals' profit changed over the last four quarters?

Accepted Answer

Net profit attributable to shareholders by quarter: ₹108 crore in Q3 FY26, ₹132 crore in Q4 FY26, ₹74.3 crore in Q1 FY27 and ₹125 crore in Q2 FY27. That is ₹439 crore over the four quarters, up 96.1% from ₹224 crore in the four quarters before. Revenue from operations: ₹393 crore, ₹433 crore, ₹330 crore and ₹437 crore.

Question 11

When did Acutaas Chemicals announce its Q2 FY27 results?

Accepted Answer

On Tuesday, 27 October 2026 at 12:50 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 17 October 2025.

Question 12

When will Acutaas Chemicals announce its Q3 FY27 results?

Accepted Answer

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Question 13

Where do these Acutaas Chemicals figures come from?

Accepted Answer

From Acutaas Chemicals' own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 27 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	437	306	+42.7%
EBITDA	176	95.3	+84.6%
EBITDA margin	40.3%	31.1%	+9.1 pts
Profit before tax	167	96.2	+74.0%
Net profit	123	71.9	+71.4%
EPS	₹15.29	₹8.82	+73.4%

Expenses
	437	330	433	393	306	207	308	275	247	177	225	166	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	5.1	1.8	11.1	4.7	9.8	15.9	5.8	1.7	8.4	1.0	1.3	3.5
	442	331	444	398	316	223	314	277	255	178	226	170
	156	166	184	176	131	104	165	157	143	105	134	86.1
	8.9	−27.0	−19.2	−6.8	4.2	−7.2	−2.1	−9.4	−3.4	−2.7	0.6	8.9
	42.1	39.6	33.3	29.9	29.4	25.1	23.3	21.7	19.6	19.1	17.0	16.1
	1.0	1.1	1.2	0.9	0.6	0.6	0.6	0.7	0.5	4.4	2.1	2.5
	12.7	9.8	9.6	9.8	8.4	8.1	7.3	6.3	6.8	6.2	4.9	3.8
	53.5	38.3	51.5	43.5	46.1	34.4	37.7	36.8	38.6	25.8	29.7	28.8
	275	228	260	253	220	165	231	213	205	158	189	146
	176	113	184	151	95.3	50.9	85.0	68.7	48.9	29.5	43.2	26.5
	163	103	174	141	86.9	42.8	77.7	62.3	42.1	23.3	38.3	22.8
Profit
	167	104	184	145	96.2	58.1	82.8	63.3	50.0	20.0	37.5	23.7
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.3	0.0
	167	104	184	145	96.2	58.1	82.8	63.3	50.0	20.0	37.2	23.7
	39.1	27.3	48.8	36.4	19.3	12.7	15.5	17.0	12.1	4.5	9.0	5.3
	5.1	1.7	0.7	2.1	5.1	1.3	4.6	0.9	0.4	0.7	2.6	0.6
	44.2	28.9	49.5	38.4	24.3	14.1	20.1	17.9	12.5	5.3	11.5	5.9
	123	75.0	134	106	71.9	44.0	62.7	45.4	37.6	14.7	25.7	17.8
	123	75.0	134	106	71.9	44.0	62.7	45.4	37.6	14.7	25.7	17.8
	26.9	−2.2	−3.2	0.2	−0.3	−0.0	0.3	−0.1	−0.3	−0.0	0.1	−0.0
	150	72.8	131	106	71.6	44.0	63.0	45.3	37.3	14.7	25.8	17.8
	125	74.3	132	108	72.2	44.3	62.5	45.0	37.3	13.9	25.1	16.8
	−2.0	0.7	2.5	−1.7	−0.4	−0.3	0.2	0.5	0.2	0.7	0.5	1.1
Per share
	₹15.29	₹9.07	₹16.09	₹13.19	₹8.82	₹5.41	₹7.80	₹11.35	₹9.38	₹3.67	₹6.86	₹4.83
	₹15.24	₹9.04	₹16.04	₹13.10	₹8.82	₹5.41	₹7.80	₹11.35	₹9.38	₹3.67	₹6.85	₹4.83
Other comprehensive income — detail
	26.9	−2.2	−3.2	0.2	−0.3	−0.0	0.3	—	—	—	—	—
	−0.5	−0.1	0.3	0.2	−0.4	−0.0	0.4	−0.1	−0.3	−0.0	0.1	−0.0
	−0.1	−0.0	0.1	−0.1	−0.1	−0.0	0.1	—	—	—	—	—
	27.3	−2.1	−3.4	—	—	—	—	—	—	—	0.0	0.0
	146	72.1	129	108	72.0	44.3	62.8	44.8	37.1	13.9	25.2	16.7
	4.3	0.7	2.5	−1.7	−0.4	−0.3	0.2	0.5	0.2	0.7	0.5	1.1
Per share — as-filed variants
	₹15.29	₹9.07	₹16.09	₹13.19	₹8.82	₹5.41	₹7.80	₹11.35	₹9.38	₹3.67	₹6.86	₹4.83
	₹15.24	₹9.04	₹16.04	₹13.10	₹8.82	₹5.41	₹7.80	₹11.35	₹9.38	₹3.67	₹6.85	₹4.83
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	271	191	268	224	171	110	146	127	107	74.3	90.0	71.4
	62.1%	57.9%	62.0%	57.0%	55.8%	53.2%	47.3%	46.2%	43.4%	42.1%	40.0%	42.9%
Adjusted (ex-exceptional items) — derived
	167	104	184	145	96.2	58.1	82.8	63.3	50.0	20.0	37.5	23.7
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.3	0.0
	123	75.0	134	106	71.9	44.0	62.7	45.4	37.6	14.7	25.9	17.8
	₹15.29	₹9.07	₹16.09	₹13.19	₹8.82	₹5.41	₹7.80	₹11.35	₹9.38	₹3.67	₹6.92	₹4.83

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	166.4	225.0	176.7	246.7	275.0	308.5	207.2	306.2	393.2	432.8	329.7	436.9
Other Income	3.5	1.3	1.0	8.4	1.7	5.8	15.9	9.8	4.7	11.1	1.8	5.1
Total Income	169.9	226.3	177.7	255.2	276.7	314.3	223.2	316.0	397.9	443.9	331.5	442.0
Expenses
+ Cost of Materials Consumed	86.1	134.4	105.1	143.0	157.2	164.6	104.1	131.2	176.0	183.7	165.8	156.5
+ Changes in Inventories	8.9	0.6	-2.7	-3.4	-9.4	-2.1	-7.2	4.2	-6.8	-19.2	-27.0	8.9
+ Employee Benefit Expense	16.1	17.0	19.1	19.6	21.7	23.3	25.1	29.4	29.9	33.3	39.6	42.1
+ Finance Costs	2.5	2.1	4.4	0.5	0.7	0.6	0.6	0.6	0.9	1.2	1.1	1.0
+ Depreciation & Amortisation	3.8	4.9	6.2	6.8	6.3	7.3	8.1	8.4	9.8	9.6	9.8	12.7
+ Other Expenses	28.8	29.7	25.8	38.6	36.8	37.7	34.4	46.1	43.5	51.5	38.3	53.5
Total Expenses	146.2	188.8	157.8	205.1	213.3	231.4	165.1	219.9	253.2	260.1	227.6	274.7
EBITDA	26.5	43.2	29.5	48.9	68.7	85.0	50.9	95.3	150.7	183.5	113.1	176.0
EBIT	22.8	38.3	23.3	42.1	62.3	77.7	42.8	86.9	140.8	173.9	103.2	163.3
Profit
PBT before Exceptional Items	23.7	37.5	20.0	50.0	63.3	82.8	58.1	96.2	144.7	183.8	103.9	167.4
+ Exceptional Items	0.0	-0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Pretax Income	23.7	37.2	20.0	50.0	63.3	82.8	58.1	96.2	144.7	183.8	103.9	167.4
+ Current Tax	5.3	9.0	4.5	12.1	17.0	15.5	12.7	19.3	36.4	48.8	27.3	39.1
+ Deferred Tax	0.6	2.6	0.7	0.4	0.9	4.6	1.3	5.1	2.1	0.7	1.7	5.1
Tax Expense	5.9	11.5	5.3	12.5	17.9	20.1	14.1	24.3	38.4	49.5	28.9	44.2
Net Income	17.8	25.7	14.7	37.6	45.4	62.7	44.0	71.9	106.2	134.3	75.0	123.1
+ Net Income — Continuing Ops	17.8	25.7	14.7	37.6	45.4	62.7	44.0	71.9	106.2	134.3	75.0	123.1
+ Other Comprehensive Income	-0.0	0.1	-0.0	-0.3	-0.1	0.3	-0.0	-0.3	0.2	-3.2	-2.2	26.9
Total Comprehensive Income	17.8	25.8	14.7	37.3	45.3	63.0	44.0	71.6	106.5	131.1	72.8	150.1
Net Income to Common	16.8	25.1	13.9	37.3	45.0	62.5	44.3	72.2	108.0	131.8	74.3	125.2
Minority Interest	1.1	0.5	0.7	0.2	0.5	0.2	-0.3	-0.4	-1.7	2.5	0.7	-2.0
Per Share
Basic EPS	4.83	6.86	3.67	9.38	11.35	7.80	5.41	8.82	13.19	16.09	9.07	15.29
Diluted EPS	4.83	6.85	3.67	9.38	11.35	7.80	5.41	8.82	13.10	16.04	9.04	15.24
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	0.3	-0.0	-0.3	0.2	-3.2	-2.2	26.9
+ Items NOT to be Reclassified to P&L	-0.0	0.1	-0.0	-0.3	-0.1	0.4	-0.0	-0.4	0.2	0.3	-0.1	-0.5
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.1	-0.0	-0.1	-0.1	0.1	-0.0	-0.1
+ Items to be Reclassified to P&L	0.0	0.0	—	—	—	—	—	—	—	-3.4	-2.1	27.3
Comprehensive Income — Owners of Parent	16.7	25.2	13.9	37.1	44.8	62.8	44.3	72.0	108.2	128.6	72.1	145.8
Comprehensive Income — Non-controlling Interests	1.1	0.5	0.7	0.2	0.5	0.2	-0.3	-0.4	-1.7	2.5	0.7	4.3
Per Share — as-filed variants
Basic EPS — Continuing Operations	4.83	6.86	3.67	9.38	11.35	7.80	5.41	8.82	13.19	16.09	9.07	15.29
Diluted EPS — Continuing Operations	4.83	6.85	3.67	9.38	11.35	7.80	5.41	8.82	13.10	16.04	9.04	15.24
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	71.4	90.0	74.3	107.2	127.2	146.0	110.3	170.7	224.0	268.3	190.9	271.5
Gross Margin %	42.92	39.99	42.08	43.44	46.25	47.33	53.25	55.76	56.97	62.00	57.91	62.14
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	23.7	37.5	20.0	50.0	63.3	82.8	58.1	96.2	144.7	183.8	103.9	167.4
− Exceptional Items (reconciliation)	0.0	-0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	17.8	25.9	14.7	37.6	45.4	62.7	44.0	71.9	106.2	134.3	75.0	123.1
EPS Adj	4.83	6.92	3.67	9.38	11.35	7.80	5.41	8.82	13.19	16.09	9.07	15.29
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00
Paid Up Equity Capital	36.9	36.9	40.9	40.9	40.9	40.9	40.9	40.9	40.9	40.9	40.9	40.9

Acutaas Chemicals quarterly results

Every quarter

Acutaas Chemicals Ltd.

Acutaas Chemicals Q2 FY27 results (July–September 2026)

Q2 FY27 at a glance · consolidated

Questions